Attitudes, perceptions, and use of marijuana in youth with multiple sclerosis
- 697 Downloads
Studies have shown a negative impact on cognition and brain volume in marijuana-using adult multiple sclerosis (MS) patients and healthy adolescents. Given that onset of MS during childhood and adolescence negatively impacts brain growth and the normal maturation of neuronal networks, the addition of marijuana exposure in these youth may be even more harmful.
Determine attitudes toward and prevalence of recreational marijuana use in MS youth.
We surveyed 52 consecutive pediatric-onset MS patients from three pediatric MS centers in the United States. Participants answered a structured questionnaire to capture attitudes toward marijuana and personal use habits, if present.
Nearly half reported use of marijuana, with the majority beginning to use in mid-to-late adolescence. The most popular reasons for using marijuana were relaxation (72%), improvement of medical problems (64%), and stress reduction (52%). Over half (64%) of marijuana users perceived it to have negative effects on memory and focus. Cost and access were not barriers to use, despite all respondents being less than age 21.
Youth with MS endorse recreational marijuana as safe, and many use marijuana frequently despite appreciating a negative impact on memory. More detailed understanding of the long-term impact of marijuana use in youth with MS is needed.
KeywordsCannabis Marijuana Multiple sclerosis Pediatric Adolescent
The authors thank Amy Lavery, Gerry Liu, and Brooke Henry for assistance in study initiation and recruitment. We would also like to thank Isabella Dumitrescu for her assistance in creating the questionnaire employed in this study.
Compliance with ethical standards
Conflicts of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
This study was approved by the appropriate ethics committees and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.
- 1.Johnston LD, O’Malley PM, Miech RA, Bachman JG, Schulenberg JE (2014) Monitoring the future national survey results on drug use, 1975–2014: overview, key findings on adolescent drug use. http://www.monitoringthefuture.org/pubs/monographs/mtf-overview2014.pdf. Accessed 12 June 2017
- 2.Johnston LD, O’Malley PM, Miech RA, Bachman JG, Schulenberg JE (2017) Monitoring the future national survey results on drug use, 1975–2016: overview, key findings on adolescent drug use. Institute for Social Research, The University of Michigan, Ann Arbor. http://monitoringthefuture.org/pubs/monographs/mtf-overview2016.pdf. Accessed 2017
- 4.Koppel BS, Brust JC, Fife T, Bronstein J, Youssof S, Gronseth G et al (2014) Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the guideline development subcommittee of the American Academy of Neurology. Neurology 82(17):1556–1563CrossRefPubMedPubMedCentralGoogle Scholar
- 6.Novotna A, Mares J, Ratcliffe S, Novakova I, Vachova M, Zapletalova O et al (2011) A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex((R))), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol 18(9):1122–1131CrossRefPubMedGoogle Scholar
- 8.Vaney C, Heinzel-Gutenbrunner M, Jobin P, Tschopp F, Gattlen B, Hagen U et al (2004) Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study. Mult Scler 10(4):417–424CrossRefPubMedGoogle Scholar
- 15.Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC et al (2013) International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 19(10):1261–1267CrossRefPubMedGoogle Scholar
- 16.National Health and Nutrition Examination Survey (2008) Drug use questionnaire. https://wwwn.cdc.gov/nchs/data/nhanes/2011-2012/questionnaires/duq_acasi.pdf. Accessed 2015
- 17.Pew Research Centre (2014) America’s New drug policy landscape. http://www.people-press.org/2014/04/02/americas-new-drug-policy-landscape/. Accessed 2015